{"id":"vancomycin-oral-liquid","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108930","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action prevents the formation of a functional cell wall, ultimately leading to bacterial cell lysis and death. Vancomycin is a glycopeptide antibiotic that has been used to treat various bacterial infections.","oneSentence":"Vancomycin oral liquid inhibits bacterial cell wall synthesis by binding to the D-alanyl-D-alanine terminus of cell wall precursors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:55:31.507Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of Clostridioides difficile infection"},{"name":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections"}]},"trialDetails":[{"nctId":"NCT06889701","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants","status":"RECRUITING","sponsor":"TenNor Therapeutics Inc.","startDate":"2025-04-03","conditions":"Periprosthetic Joint Infection (PJI)","enrollment":33},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT06126731","phase":"PHASE1, PHASE2","title":"Combination Study of Antibiotics With Enzalutamide (PROMIZE)","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-11-02","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":39},{"nctId":"NCT07221370","phase":"PHASE2, PHASE3","title":"Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients","status":"RECRUITING","sponsor":"Riverside University Health System Medical Center","startDate":"2024-10-21","conditions":"Clostridium Difficile Infection, Vancomycin Resistant Enterococci Infection","enrollment":176},{"nctId":"NCT06197308","phase":"EARLY_PHASE1","title":"Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-03-01","conditions":"Primary Sclerosing Cholangitis","enrollment":28},{"nctId":"NCT02218372","phase":"PHASE3","title":"A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2015-01-09","conditions":"Clostridium Difficile-associated Diarrhea (CDAD)","enrollment":148},{"nctId":"NCT06503978","phase":"PHASE2","title":"Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gut-Brain-Axis Therapeutics Inc.","startDate":"2024-08-20","conditions":"Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation","enrollment":60},{"nctId":"NCT06321796","phase":"PHASE2","title":"Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Gut-Brain-Axis Therapeutics Inc.","startDate":"2024-02-27","conditions":"Pitt Hopkins Syndrome","enrollment":20},{"nctId":"NCT02922816","phase":"PHASE1","title":"FMT for MDRO Colonization After Infection in Renal Transplant Recipients","status":"TERMINATED","sponsor":"Emory University","startDate":"2016-12-01","conditions":"Infection Due to Resistant Organism","enrollment":11},{"nctId":"NCT00501150","phase":"NA","title":"Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2005-09","conditions":"Gram-positive Bacterial Infections, Staphylococcal Infections","enrollment":211},{"nctId":"NCT03388268","phase":"PHASE4","title":"TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-12-29","conditions":"Clostridium Difficile Infection, Diarrhea","enrollment":15},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT02237859","phase":"PHASE4","title":"Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection","status":"UNKNOWN","sponsor":"Corewell Health West","startDate":"2014-08","conditions":"Clostridium Difficile Infection","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vancomycin oral liquid","genericName":"Vancomycin oral liquid","companyName":"Astellas Pharma Europe B.V.","companyId":"astellas-pharma-europe-b-v","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vancomycin oral liquid inhibits bacterial cell wall synthesis by binding to the D-alanyl-D-alanine terminus of cell wall precursors. Used for Treatment of Clostridioides difficile infection, Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}